📊 BLLN Key Takeaways
Investment Thesis
BillionToOne demonstrates exceptional revenue growth (100% YoY) with strong gross margins (68.3%) and improving profitability, though operating leverage remains constrained. The company maintains excellent financial health with fortress-like liquidity (11.69x current ratio) and minimal leverage (0.12x debt/equity), providing substantial runway for operational scaling and growth investments.
BLLN Strengths
- Outstanding revenue growth at 100% YoY with net income acceleration (155.4% YoY)
- Exceptional gross margin of 68.3% indicates strong pricing power and low cost of goods
- Fortress balance sheet with $496M cash, minimal debt ($57.2M), and strong liquidity ratios
- Positive free cash flow generation ($15.7M) supporting sustainability of growth
BLLN Risks
- Operating margin severely compressed at 5.3% despite 68.3% gross margin, indicating high operating expense burden and limited operating leverage
- Net margin of only 2.4% suggests profitability highly sensitive to operational efficiency improvements
- Minimal ROE (1.6%) and ROA (1.2%) indicate inefficient capital deployment relative to asset base
- Rapid growth trajectory may not be sustainable; revenue doubling creates execution risk at scale
Key Metrics to Watch
- Operating margin expansion and path to operating leverage as revenue scales
- Free cash flow sustainability and conversion of revenue growth to bottom-line profitability
- Operating expense ratio trends relative to revenue growth
- Return on assets and equity improvement trajectory
BLLN Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 11.69x current ratio provides a solid financial cushion.
BLLN Profitability Ratios
BLLN vs Healthcare Sector
How BillionToOne, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BLLN Balance Sheet & Liquidity
BLLN 5-Year Financial Trend
5-Year Trend Summary: BillionToOne, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-8.45 indicates the company is currently unprofitable.
BLLN Growth Metrics (YoY)
BLLN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $38.4M | $1.5M | $0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BLLN Capital Allocation
BLLN SEC Filings
Access official SEC EDGAR filings for BillionToOne, Inc. (CIK: 0002070849)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BLLN
What is the AI rating for BLLN?
BillionToOne, Inc. (BLLN) has an AI rating of BUY with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BLLN's key strengths?
Outstanding revenue growth at 100% YoY with net income acceleration (155.4% YoY). Exceptional gross margin of 68.3% indicates strong pricing power and low cost of goods.
What are the risks of investing in BLLN?
Operating margin severely compressed at 5.3% despite 68.3% gross margin, indicating high operating expense burden and limited operating leverage. Net margin of only 2.4% suggests profitability highly sensitive to operational efficiency improvements.
What is BLLN's revenue and growth?
BillionToOne, Inc. reported revenue of $305.1M.
Does BLLN pay dividends?
BillionToOne, Inc. does not currently pay dividends.
Where can I find BLLN SEC filings?
Official SEC filings for BillionToOne, Inc. (CIK: 0002070849) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BLLN's EPS?
BillionToOne, Inc. has a diluted EPS of $0.14.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.